A case of oral cancer with preoperative transcatheter aortic valve implantation for aortic stenosis: A case report

Kato,Tomoki; Matayoshi,Akira; Nakasone,Toshiyuki

doi:10.3892/mco.2020.2106

A case of oral cancer with preoperative transcatheter aortic valve implantation for aortic stenosis: A case report

Authors:
- Tomoki Kato
- Akira Matayoshi
- Toshiyuki Nakasone
View Affiliations

Affiliations: Department of Oral and Maxillofacial Functional Rehabilitation, Graduate School of Medicine, University of The Ryukyus, Nishihara, Okinawa 903‑0215, Japan, Department of Oral and Maxillofacial Surgery, University Hospital of The Ryukyus, Nishihara, Okinawa 903‑0215, Japan
Published online on: July 31, 2020 https://doi.org/10.3892/mco.2020.2106
Article Number: 36
Copyright: © Kato et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aortic valve stenosis [or aortic stenosis, (AS)] is a risk factor in non‑cardiac surgery. Guidelines from the European Heart Association recommended that AS treatment should be applied prior to non‑cardiac surgery. Transcatheter aortic valve implantation (TAVI) is a method of minimally invasive AS treatment. The present study reports a case of tongue excision and neck dissection after TAVI for a patient with tongue cancer and AS. A 79‑year‑old woman was diagnosed with AS following preoperative examination for tongue cancer. The patient was judged as a high‑risk case for open‑heart surgery after consultation with staff at the University Hospital of The Ryukyus. It was concluded that TAVI should be performed prior to cancer surgery. On day 21 following TAVI, cancer surgery was performed and the patient was discharged from hospital 22 days after tongue cancer surgery. To the best of our knowledge, there is no report of oral cancer surgery after TAVI. TAVI is generally used as a short‑term treatment strategy for AS associated with head and neck cancer due to its minimally invasive nature. In the present case, oral cancer surgery was performed closely following TAVI without serious complications. The case demonstrated that TAVI might be useful for severe AS patients with high surgical risk prior to cancer resection surgery. However, further cases are required to confirm the safety and effectiveness of TAVI treatment strategies.

View Figures

View References

1	Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, et al: 2014 ESC/ESA guidelines on non-cardiac surgery: Cardiovascular assessment and management: The joint task force on non-cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 35:2383–2431. 2014.PubMed/NCBI View Article : Google Scholar
2	Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F and Leon MB: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation. 106:3006–3008. 2002.PubMed/NCBI View Article : Google Scholar
3	Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, et al: Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: Results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 6:604–614. 2013.PubMed/NCBI View Article : Google Scholar
4	Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, et al: 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER1): A randomised controlled trial. Lancet. 385:2477–2484. 2015.PubMed/NCBI View Article : Google Scholar
5	Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, et al: 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial. Lancet. 385:2485–2491. 2015.PubMed/NCBI View Article : Google Scholar
6	Scott BH, Seifert FC, Glass PS and Grimson R: Blood use in patients undergoing coronary artery bypass surgery: Impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg. 97:958–963. 2003.PubMed/NCBI View Article : Google Scholar
7	Pinto CA, Marcella S, August DA, Holland B, Kostis JB and Demissie K: Cardiopulmonary bypass has a modest association with cancer progression: A retrospective cohort study. BMC Cancer. 13(519)2013.PubMed/NCBI View Article : Google Scholar
8	Tamai K, Okamura S, Kitahara T, Minoji T, Takabatake H, Watanabe N, Yamamura N, Fukuchi N, Ebisui C, Yokouchi H and et al: Laparoscopic colectomy after transcatheter aortic valve implantation in an elderly patient with obstructive descending colon cancer and severe aortic stenosis: A case report. Surg Case Rep. 5(102)2019.PubMed/NCBI View Article : Google Scholar
9	Sakai T, Yahagi K, Miura S, Hoshino T, Yokota T, Tanabe K and Ikeda S: Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis. J Thorac Dis. 10:E387–E390. 2018.PubMed/NCBI View Article : Google Scholar
10	Tanaka T, Yahagi K, Okuno T, Horiuchi Y, Kusuhara T, Yokozuka M, Miura S and Tanabe K, Miura S and Tanabe K and Tanabe K: Transcatheter aortic valve implantation in a patient with severe aortic valve stenosis, colon cancer, and obstructive ileus: A case report. J Cardiol Cases. 17:163–166. 2018.PubMed/NCBI View Article : Google Scholar
11	Okuno T, Yahagi K, Horiuchi Y, Sato Y, Tanaka T, Koseki K, Osanai A, Yokozuka M, Miura S and Tanabe K: The role of transcatheter aortic valve replacement in the patients with severe aortic stenosis requiring major non-cardiac surgery. Cardiovasc Interv Ther. 13:345–351. 2019.PubMed/NCBI View Article : Google Scholar
12	Nagata H, Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, Minami M, Mizote I, Sakata Y, Maeda K, et al: Two cases of lobectomy for lung cancer after transcatheter aortic valve implantation. Surg Case Rep. 4(139)2018.PubMed/NCBI View Article : Google Scholar
13	Bach DS, Cimino N and Deeb GM: Unopoerated patients with severe aortic stenosis. J Am Coll Cardiol. 50:2018–2019. 2007.PubMed/NCBI View Article : Google Scholar